Dual-Tracer PET Assessment of Complete Amyloid and Tau Clearance in a Male Patient With Alzheimer Disease (EANM 2026) - Sep 29, 2026 - Abstract #OP-703; Pres time: Oct 20, 2026; 03:00 PM - 04:30 PM; Location: Hall F1; "This case highlights the critical importance of early AD intervention and dual-tracer PET for comprehensive therapeutic efficacy assessment."
Clinical • Alzheimer's Disease • CNS Disorders • Cognitive Disorders
|